Correvio Pharma Corp. Depreciation and Amortization Expense
Correvio Pharma Corp. reported Depreciation and Amortization Expense of $3.94 million for the 12-month period ending 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DepreciationAndAmortization · last filed 2020-04-30
| Period end | Depreciation, Depletion and Amortization, Nonproduction 12 month |
|---|---|
| 2019-12-31 | $3.94M 20-F · filed 2020-04-30 |
| 2018-12-31 | $4.14M 20-F · filed 2020-04-30 |
| 2017-12-31 | $3.52M 20-F · filed 2020-04-30 |
| 2016-12-31 | $2.98M 20-F · filed 2018-04-30 |
| 2015-12-31 | $2.18M 20-F · filed 2018-04-30 |
| 2014-12-31 | $2.15M 40-F · filed 2016-03-29 |
| 2013-12-31 | $649.00K 40-F · filed 2015-03-27 |
| 2012-12-31 | $1.23M 40-F/A · filed 2014-04-30 |
| 2011-12-31 | $1.09M 20-F/A · filed 2013-04-18 |
| 2010-12-31 | $1.15M 20-F/A · filed 2013-04-18 |